Events

LIFE+ 2026 info days
APR
Tue
28
APR
Wed
29
APR
Thu
30

Starts in 1 week from now

Location

Online

Programmes
Agro-Food, Environment

CINEA is organising an info day for the LIFE Calls for proposals. The 2026 Calls are due to be published on 21 April 2026 on the EU Funding & Tenders Portal.

The programme covers the 2026 call priorities, the four LIFE sub-programmes, and guidance on preparing a strong proposal. The information sessions are designed to help potential applicants understand the call topics and prepare competitive proposals across the LIFE programme.

Participants can follow the live stream and ask questions in real time via Slido. They can register via this webpage

Please note that NCP Flanders is not a contact point of the LIFE program but we do inform the cluster 6 subscribers of the related events.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.